Similarly, we found that zebrafish systemically infected with WT Pg W83 along with KYT1 and KYT36 displayed significantly reduced mortality and disease symptoms, suggesting not only that these inhibitory molecules show therapeutic promise but that the zebrafish infection model may be used to screen other therapeutic agents and strategies aimed at Pg or other bacterial-mediated systemic diseases. This evidence concerns the gene JUP and infection.